Ratnakar Securities Pvt. Ltd.

MAX HEALTHCARE INSTITUTE LTD.

NSE : MAXHEALTHBSE : 543220ISIN CODE : INE027H01010Industry : Hospital & Healthcare ServicesHouse : Max

BSE1166.60-14.45 (-1.22 %)

PREV CLOSE ( ) 1181.05

OPEN PRICE ( ) 1180.75

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 64600

TODAY'S LOW / HIGH ( )1160.00 1199.90

52 WK LOW / HIGH ( )630.75 1215

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-06 2001

Management Info

Abhay Soi - Chairman Abhay Soi - Managing Director

Registered Office

Address 401, 4th Floor, Man Excellenza,S. V. Road,Vile Parle (West),
Mumbai,
Maharashtra-400056

Phone 022-26100461 / 62

Email secretarial@maxhealthcare.com / investors@maxhealthcare.com

Website www.maxhealthcare.in

Registrars Details

Link Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

12Nov Max Healthcare Institute completes acq
Max Healthcare Institute has completed the acquisition of 100% equity st..

12Nov Max Healthcare Institute informs abou
In continuation to its earlier intimations dated September 13, 2024, Sep..

12Nov Max Healthcare Institute gains on comp
Max Healthcare Institute is currently trading at Rs. 1036.05, up by 10.8..

05Nov Grant Of Options Under Max Healthcare
Grant of options under Max Healthcare Institute Limited - Employee Stock..

27Sep Max Healthcare Institute to acquire 63
Max Healthcare Institute has executed a Share Purchase Agreement (SPA) w..

Financials

in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	2313	6872.6
Gross Profit	3181.5	8649.6
Operating Profit	3581.8	10332.6
Net Sales	6861.1	23413.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Suraksha Diagnostic (BSE) 412.60 (0.99%)	M.Cap ( in Cr)2148.85
Soni Medicare (BSE) 38.65 (4.60%)	M.Cap ( in Cr)16.48
Sharma Hospitals (BSE) 80.28 (1.99%)	M.Cap ( in Cr)26.36
Fortis MalarHospital (BSE) 59.08 (1.18%)	M.Cap ( in Cr)110.73
Choksi Lab (BSE) 63.17 (0.29%)	M.Cap ( in Cr)44.00

Shareholding Pattern

	NON-INSTITUTION	3.83%
	PROMOTERS	23.74%
	FI/BANKS/INSURANCE	2.89%
	MUTUAL FUNDS/UTI	11.56%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Nifty MidSmall...	13.29
DSP Nifty Healthcare ETF	7.98
ICICI Pru Nifty Hea...	7.98
Axis NIFTY Healthcare ETF	7.98
Aditya Birla SL Nif...	7.98
SBI Healthcare Opp ...	5.89

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

MAX HEALTHCARE INSTITUTE LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES